Literature DB >> 23404775

Is there a role for new oral anticoagulants as primary and secondary stroke prevention in atrial fibrillation and intracranial stenosis?

Claudia Stöllberger1, Adam Bastovansky, Josef Finsterer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23404775     DOI： 10.1007/s11239-013-0884-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  14 in total

1.  Rivaroxaban in patients with a recent acute coronary syndrome.

Authors:  Jessica L Mega; Eugene Braunwald; Stephen D Wiviott; Jean-Pierre Bassand; Deepak L Bhatt; Christoph Bode; Paul Burton; Marc Cohen; Nancy Cook-Bruns; Keith A A Fox; Shinya Goto; Sabina A Murphy; Alexei N Plotnikov; David Schneider; Xiang Sun; Freek W A Verheugt; C Michael Gibson
Journal:  N Engl J Med       Date:  2011-11-13       Impact factor: 91.245

2.  Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.

Authors:  Marc I Chimowitz; Michael J Lynn; Harriet Howlett-Smith; Barney J Stern; Vicki S Hertzberg; Michael R Frankel; Steven R Levine; Seemant Chaturvedi; Scott E Kasner; Curtis G Benesch; Cathy A Sila; Tudor G Jovin; Jose G Romano
Journal:  N Engl J Med       Date:  2005-03-31       Impact factor: 91.245

3.  Increases in cerebral atherosclerosis according to CHADS2 scores in patients with stroke with nonvalvular atrial fibrillation.

Authors:  Young Dae Kim; Myoung Jin Cha; Jinkwon Kim; Dong Hyun Lee; Hye Sun Lee; Chung Mo Nam; Hyo Suk Nam; Ji Hoe Heo
Journal:  Stroke       Date:  2011-02-24       Impact factor: 7.914

4.  Apixaban with antiplatelet therapy after acute coronary syndrome.

Authors:  John H Alexander; Renato D Lopes; Stefan James; Rakhi Kilaru; Yaohua He; Puneet Mohan; Deepak L Bhatt; Shaun Goodman; Freek W Verheugt; Marcus Flather; Kurt Huber; Danny Liaw; Steen E Husted; Jose Lopez-Sendon; Raffaele De Caterina; Petr Jansky; Harald Darius; Dragos Vinereanu; Jan H Cornel; Frank Cools; Dan Atar; Jose Luis Leiva-Pons; Matyas Keltai; Hisao Ogawa; Prem Pais; Alexander Parkhomenko; Witold Ruzyllo; Rafael Diaz; Harvey White; Mikhail Ruda; Margarida Geraldes; Jack Lawrence; Robert A Harrington; Lars Wallentin
Journal:  N Engl J Med       Date:  2011-07-24       Impact factor: 91.245

5.  Stenting versus aggressive medical therapy for intracranial arterial stenosis.

Authors:  Marc I Chimowitz; Michael J Lynn; Colin P Derdeyn; Tanya N Turan; David Fiorella; Bethany F Lane; L Scott Janis; Helmi L Lutsep; Stanley L Barnwell; Michael F Waters; Brian L Hoh; J Maurice Hourihane; Elad I Levy; Andrei V Alexandrov; Mark R Harrigan; David Chiu; Richard P Klucznik; Joni M Clark; Cameron G McDougall; Mark D Johnson; G Lee Pride; Michel T Torbey; Osama O Zaidat; Zoran Rumboldt; Harry J Cloft
Journal:  N Engl J Med       Date:  2011-09-07       Impact factor: 91.245

6.  Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.

Authors:  Greg C Flaker; John W Eikelboom; Olga Shestakovska; Stuart J Connolly; Scott Kaatz; Andrzej Budaj; Steen Husted; Salim Yusuf; Gregory Y H Lip; Robert G Hart
Journal:  Stroke       Date:  2012-10-02       Impact factor: 7.914

7.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

8.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

9.  Atherothrombotic ischemic stroke in patients with atrial fibrillation.

Authors:  Gulcin Benbir; Derya Uluduz; Birsen Ince; Melda Bozluolcay
Journal:  Clin Neurol Neurosurg       Date:  2007-04-30       Impact factor: 1.876

10.  The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation.

Authors:  Laurent Azoulay; Sophie Dell'Aniello; Teresa Simon; Christel Renoux; Samy Suissa
Journal:  Thromb Haemost       Date:  2013-01-10       Impact factor: 5.249
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.